TOUJEO CARTRIDGE (Insulin Glargine (300u/ml))

Toujeo 300U/ml Injection is a long-acting insulin formulation utilized in the management of type 1 and type 2 diabetes in both adults and pediatric patients. This medication maintains a constant level of insulin in the bloodstream throughout the day, which assists in regulating blood glucose levels effectively and helps to mitigate the risk of diabetes-related complications. Toujeo may be prescribed alone or along with fast-acting insulins or other antidiabetic medications, depending on individual patient needs. It is essential for healthcare providers to instruct patients on the proper subcutaneous injection technique to ensure effective administration. Adhering to the prescribed dosage is crucial for achieving optimal therapeutic outcomes. Abrupt discontinuation of this medication may lead to dangerously elevated blood sugar levels, increasing the likelihood of severe health issues. Toujeo is one component of a comprehensive diabetes management plan that should also include a balanced diet, consistent physical activity, and weight management strategies as recommended by a healthcare professional. One of the most prevalent side effects associated with Toujeo is hypoglycemia (low blood sugar), which can be prevented by adhering to the correct dosage, maintaining regular meal intake, and routinely monitoring blood glucose levels. Excessive alcohol consumption may also contribute to decreased blood sugar levels. Other frequently reported side effects include peripheral edema, lipodystrophy, allergic reactions, injection site discomfort and reactions, skin itching and rashes, as well as weight gain.